Pharmabiz

MAHE sets up advanced BSL-3 facility for high-containment biomedical research

MAHE sets up advanced BSL-3 facility for high-containment biomedical research: Our Bureau, Bengaluru Monday, October 26, 2026, 16:30 Hrs [IST] Manipal Academy of Higher Education ...
Pharmabiz

DSS Takara Bio-supported breast-cancer R&D lays strong foundation for future advances in treatment

DSS Takara Bio-supported breast-cancer R&D lays strong foundation for future advances in treatment: Our Bureau, Bengaluru Monday, October 26, 2026, 16:15 Hrs [IST] DSS Takara Bio ...
Pharmabiz

WHO launches working papers on traditional medicine

The WHO Global Traditional Medicine Centre is launching a series of working papers designed to document and examine traditional, complementary and integrative medicine (TCIM) worldwide. The inaugural ...
Pharmabiz

AIG Hospitals and Boston Scientific to set-up Centre of Excellence to strengthen access to therapeutic GI endoscopy

AIG Hospitals and Boston Scientific to set-up Centre of Excellence to strengthen access to therapeutic GI endoscopy: Our Bureau, Bengaluru Monday, October 26, 2026, 15:45 Hrs [IST ...
Pharmabiz

A precision T-cell therapy stalls treatment-resistant cancers in clinical trial

A precision T-cell therapy stalls treatment-resistant cancers in clinical trial: Bethesda, Maryland Monday, October 26, 2026, 15:00 Hrs [IST] Early results of the first clinical t ...
Pharmabiz

CSO raises concern over inclusion of Dr Naresh Trehan in Committee to review pharma marketing practices

CSO raises concern over inclusion of Dr Naresh Trehan in Committee to review pharma marketing practices: Our Bureau, New Delhi Monday, October 26, 2026, 14:15 Hrs [IST] Raising co ...
Pharmabiz

African Medicines Agency and EMA issue joint guidance on Ebola vaccine development

African Medicines Agency and EMA issue joint guidance on Ebola vaccine development: Amsterdam, The Netherlands Monday, October 26, 2026, 14:00 Hrs [IST] EMA’s Emergency Task For ...
Pharmabiz

PHOSSCON focuses on 60% childhood cancer survival target by 2030

PHOSSCON focuses on 60% childhood cancer survival target by 2030: Our Bureau, Mumbai Monday, October 26, 2026, 13:45 Hrs [IST] India’s goal of achieving a childhood cancer survi ...
Pharmabiz

Nearly one-third of NSQs in CDSCO September alert originate from Himachal Pradesh pharma units

Nearly one-third of NSQs in CDSCO September alert originate from Himachal Pradesh pharma units: Our Bureau, Chennai Monday, October 26, 2026, 13:35 Hrs [IST] Nearly one-third of t ...
Pharmabiz

Healthium Medtech repositions SIRONIX to target the broader orthopaedic care segment

Healthium Medtech repositions SIRONIX to target the broader orthopaedic care segment: Our Bureau, Bengaluru Monday, October 26, 2026, 13:30 Hrs [IST] Healthium Medtech, a global m ...
Pharmabiz

Cipla's InvaGen facility receives zero Form 483 observations from US FDA

Cipla's InvaGen facility receives zero Form 483 observations from US FDA: Our Bureau, Mumbai Monday, October 26, 2026, 13:15 Hrs [IST] Cipla Ltd announced that an inspection was c ...
Pharmabiz

Roche presents positive results from phase III IMAgINATION study of sefaxersen to treat primary IgA nephropathy at ASN Kidney Week 2026

Roche presents positive results from phase III IMAgINATION study of sefaxersen to treat primary IgA nephropathy at ASN Kidney Week 2026: Basel Monday, October 26, 2026, 13:00 Hrs ...